Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome

J.W. Song, S-B. Hong, C-M. Lim, Y. Koh, D.S. Kim
European Respiratory Journal 2011 37: 356-363; DOI: 10.1183/09031936.00159709
J.W. Song
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S-B. Hong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C-M. Lim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Koh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.S. Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dskim@amc.seoul.kr
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Although acute exacerbation of idiopathic pulmonary fibrosis (IPF) has become well recognised, the reported incidence and outcomes are highly variable, and risk factors are unknown. The aim of this study was to estimate the incidence, risk factors and impact of acute exacerbations, and other known causes of rapid deterioration.

This was a retrospective review of 461 patients with IPF (269 cases were biopsy-proven).

The median follow-up period was 22.9 months. Rapid deterioration requiring hospitalisation occurred in 163 (35.4%) patients, with multiple episodes in 42 patients. Acute exacerbation was the most frequent cause (55.2%), followed by infection. The 1- and 3-yr incidences of acute exacerbation were 14.2 and 20.7%, respectively. Never having smoked and low forced vital capacity (FVC) were significant risk factors. The in-hospital mortality rate was 50.0%, and the 1- and 5-yr survival rates from the initial diagnosis were 56.2 and 18.4%, respectively. Acute exacerbation was a significant predictor of poor survival after the initial diagnosis, along with increased age, low FVC and diffusing capacity of the lung for carbon monoxide, and steroid use with or without cytotoxic therapy.

1- and 3-yr incidences of acute exacerbation were 14.2 and 20.7%, respectively. Never having smoked and low FVC were risk factors. Acute exacerbation had a serious impact on the overall survival of the patients with IPF.

  • Acute exacerbation
  • idiopathic pulmonary fibrosis
  • incidence
  • prognostic factors
  • risk factors
  • survival

Footnotes

  • This article has supplementary material available from www.erj.ersjournals.com

  • Statement of Interest

    None declared.

  • Received October 9, 2009.
  • Accepted June 12, 2010.
  • ©ERS 2011
View Full Text
PreviousNext
Back to top
View this article with LENS
Vol 37 Issue 2 Table of Contents
European Respiratory Journal: 37 (2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
J.W. Song, S-B. Hong, C-M. Lim, Y. Koh, D.S. Kim
European Respiratory Journal Feb 2011, 37 (2) 356-363; DOI: 10.1183/09031936.00159709

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
J.W. Song, S-B. Hong, C-M. Lim, Y. Koh, D.S. Kim
European Respiratory Journal Feb 2011, 37 (2) 356-363; DOI: 10.1183/09031936.00159709
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Article

  • Lung volumes and survival in chronic lung allograft dysfunction
  • StO2 during weaning from mechanical ventilation
  • Automated quantification of radiological patterns predicts IPF survival
Show more Original Article

Idiopathic Pulmonary Fibrosis

  • Cell cycle dependence of ACE-2 explains downregulation in IPF
  • Pulmonary arteriole gene expression signature in IPF
  • idiopathic pulmonary fibrosis
Show more Idiopathic Pulmonary Fibrosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society